PubMed Health⌕ Search

PubMed · 12106295

Stimulus-Dependent Neuronal Oscillations in Cat Visual Cortex: Receptive Field Properties and Feature Dependence.

Abstract

Previously we have demonstrated that neurons in the striate cortex of lightly anaesthetized cats exhibit oscillatory responses at a frequency near 50 Hz in response to their preferred stimuli. Here we have used both single and multiple unit recording techniques to determine: (i) the receptive field properties and laminar distribution of cells exhibiting oscillatory responses; and (ii) the influence of changing stimulus properties on the temporal behaviour of the oscillatory responses. Oscillatory responses were detected and evaluated by computation of the autocorrelation function of the neuronal spike trains. We recorded oscillatory responses in 56% of the standard complex cells and in 12% and 11% of the simple and special complex cells. Cells exhibiting oscillatory responses were located primarily in supra- and infragranular layers. The oscillatory modulation amplitude of the autocorrelation function was enhanced by binocular stimulation (9 out of 16 cells) and reduced by combined stimulation with optimal and orthogonally orientated light bars (16 out of 21 cells). Changing stimulus orientation caused no change in the oscillation frequency of the sampled population of cells, while oscillation frequency increased monotonically with respect to stimulus velocity within the range of 1 - 12 degrees per second (10 out of 11 cells). The oscillatory modulation of the autocorrelation function increased as a function of stimulus length within the boundary of the cell's receptive field (11 out of 11 cells). In 6 out of these 11 cells, the responses did not show an oscillatory modulation if elicited by small moving spots of light. Moving stimuli were much more effective in evoking oscillatory responses than were stationary stimuli (19 out of 20 cells). In no instance, using either stationary or moving stimuli, was the phase of the oscillatory response synchronized with the stimulus. These results demonstrate functional heterogeneity among cells within striate cortex based on their temporal firing patterns and provide evidence that the temporal pattern of oscillatory cellular activity is influenced by changes in stimulus properties.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Charles M. Gray, Andreas K. Engel, Peter König, Wolf Singer. 1990. Stimulus-Dependent Neuronal Oscillations in Cat Visual Cortex: Receptive Field Properties and Feature Dependence.. https://doi.org/10.1111/j.1460-9568.1990.tb00450.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗